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RFX-B Is the Gene Responsible for the Most
Common Cause of the Bare Lymphocyte Syndrome,
an MHC Class II Immunodeficiency
1992). BLS groups B, C, and D show defects in the DNA
binding activity of RFX (Reith et al., 1988; Stimac et al.,
1991; Herrero-Sanchez et al., 1992; Hasegawa et al.,
1993). RFX defects lead to an unoccupied X and Y box
region in vivo (Kara and Glimcher, 1991; Westerheide et
Uma M. Nagarajan, Pascale Louis-Plence,²
Angela DeSandro, Roger Nilsen,
Alyssa Bushey, and Jeremy M. Boss*
Department of Microbiology and Immunology
Emory University School of Medicine
al., 1997). The Y box binds the ubiquitous factor NF-Y,Atlanta, Georgia 30322
which also interacts synergistically with RFX (Reith et al.,
1994b). In vitro, RFX, X2BP, and NF-Y form an extremely
stable complex with X-Y DNA (Louis-Plence et al., 1997).Summary
However, in vivo, the formation of this complex alone
is not sufficient for promoter activity. Activation of thisThe bare lymphocyte syndrome (BLS) is characterized
system requires the aid of the MHC class II transactiva-by the absence of MHC class II transcription and hu-
tor, CIITA (Steimle et al., 1993). CIITA contains a potentmoral- and cellular-mediated immune responses to
transcriptional activation domain but does not interactforeign antigens. Three of the four BLS genetic com-
directly with the regulatory DNA (Steimle et al., 1993;
plementation groups have defects in the activity of the
Riley et al., 1995; Zhou and Glimcher, 1995). The exact
MHC class II transcription factor RFX. We have purified mechanism of CIITA action is unknown; however, it has
the RFX complex and sequenced its three subunits. been proposed that CIITA interacts with the scaffold set
The sequence of the smallest subunit describes a up by the X and Y box DNA-binding proteins described
novel gene, termed RFX-B. RFX-B complements the above. BLS group A cell lines contain defects in the
predominant BLS complementation group (group B) transcription activator CIITA. Importantly, CIITA is cur-
and was found to be mutant in cell lines from this BLS rently the only MHC class II specific transcription factor
group. The protein has no known DNA-binding domain that is inducible by interferon-g (IFNg) (Chin et al., 1994;
but does contain three ankyrin repeats that are likely Chang et al., 1994; Steimle et al., 1994). Thus, CIITA
to be important in protein-protein interactions. expression and activity is required for the transcriptional
activation of MHC class II genes, and therefore CIITA
may function as a molecular switch.Introduction
The proteins and their corresponding genes for three
of the four BLS complementation groups have beenThe bare lymphocyte syndrome (BLS) or MHC class II
identified. Two genes have been isolated that comple-immunodeficiency disorder is a severe combined immu-
ment two of the three RFX complementation groups.nodeficiency in which MHC class II genes and HLA-DM
RFX5 and RFXAP complement groups C and D, respec-genes are not expressed (Griscelli et al., 1989; Glimcher
tively (Steimle et al., 1995; Durand et al., 1997). Theand Kara, 1992; Mach et al., 1996; Boss, 1997). Expres-
remaining group, BLS group B, with greater than 14sion of the invariant chain gene is either absent or re-
patients (Lisowska-Grospierre et al., 1994), representsduced as well. In many cases, MHC class I gene expres-
the largest of the complementation groups. Mutationssion is also reduced. This results in the immune system's
in BLS group B ablate the DNA-binding activity of RFX.inability to develop humoral- and cell-mediated immune
Coimmunoprecipitation experiments using antibodies
responses and thus the inability of patients to combat
against the 75 kDa subunit of RFX, RFX5, demonstrated
many opportunistic infections (Elhasid and Etzioni, the association of two additional proteins with molecular
1996). Four genetic complementation groups (A, B, C, masses of 41 and 33 kDa, as judged by their migration
and D) have been described (Benichou and Strominger, in SDS-PAGE (Moreno et al., 1997). All three proteins
1991; Seidl et al., 1992). All of these groups contain were required for coimmunoprecipitation of the others,
defects in the ability to transcribe from MHC class II and all are phosphoproteins. The exact identity of the
promoters, and their mutations have been ascribed to 41 and 33 kDa subunits were unknown, but because
MHC class II gene-specific transcription factors (de Pre- neither protein coimmunoprecipitated with RFX5 in
val et al., 1985; Mach et al., 1994). groups B and D cell lines, we hypothesized that one of
MHC class II genes are regulated principally at the these was likely the factor that complemented group B
transcriptional level by a compact conserved motif con- (Boss, 1997; Moreno et al., 1997).
sisting of four sequence elements termed the W/Z, X1, In this report, we have purified the RFX complex and
X2, and Y boxes (Glimcher and Kara, 1992). The X1 and sequenced all three proteins. Protein sequence determi-
X2 boxes cooperatively bind the regulatory factors RFX nation identified the 75 and 41 kDa proteins as RFX5
and X2BP, respectively (Mach et al., 1996; Boss, 1997). and RFXAP, respectively. The 33 kDa protein was en-
This X box region is necessary for expression and is coded by a novel gene that we have termed RFX-B.
sufficient for minimal MHC class II promoter activity in cDNA clones corresponding to the sequence of RFX-B
were isolated and shown to restore MHC class II expres-B lymphocytes (Sloan and Boss, 1988; Sloan et al.,
sion in BLS-group B cell lines but not cell lines from
BLS-groups A, C, or D. Analysis of the two BLS-group* To whom correspondence should be addressed (e-mail: boss@
B cell lines uncovered a small deletion encompassingmicrobio.emory.edu).
a splice site that results in a frame shift and the produc-² Present address: Laboratoire, d'Immunologie-INSERM U475, HoÃ p-
ital Saint-Eloi, 34 295 Montpelier cedex 5, France. tion of an abnormal protein. Protein homology searches
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previously (Moreno et al., 1997) (Figure 1B). RFX con-
taining fractions were pooled. Because these steps en-
riched the specific activity of the RFX complex by only
10-fold, a magnetic bead anti-RFX5 immunoaffinity resin
was developed and introduced to improve purification.
To increase the specificity of this resin for RFX, the
RFX5c polyclonal sera was first affinity purified against
peptides that were used to generate the antisera (Mor-
eno et al., 1997). This step resulted in a highly reproduc-
ible and rapid purification of the RFX protein (Figure 1B).
The exact positions of the immunoprecipitated RFX-
associated proteins were determined by labeling a por-
tion of the extract with PKA and g-32P-ATP (Figure 1B).
The bands corresponding to the 75, 41, and 33 kDa
proteins were excised for sequence determination.
Proteins were digested with trypsin and separated by
microbore HPLC. The exact masses of selected pep-
tides were determined by MALDI-TOF mass spectrome-
try. Additionally, several of the peptides were sequenced
by Edman degradation. The results of these analyses
showed that the 75 kDa protein was as expected RFX5
(data not shown). The 41 kDa protein was identified
as RFXAP by both MALDI-TOF mass spectrometry and
Edman degradation of three peptides (data not shown).
Mass spectrometry of the 33 kDa product identified a
genomic cosmid clone and a partial cDNA in the Gen-
Bank database (accession numbers AC003110 and
g2627293, respectively). Edman degradation sequenc-
ing of four peptides derived from the 33 kDa proteinFigure 1. Purification of the RFX Complex
confirmed this identification (Figure 2).(A) Schematic flow chart of protein purification on the right side and
the immunoaffinity column on the left side. (B) The videograph of
Coomassie blue stained SDS-PAGE gel containing immunoprecipi-
tated RFX prior to band excision is shown on the left. The lane RFX-B Encodes a Protein with Ankyrin Repeats
labeled IP contains the immunoprecipitation. The autoradiograph Several human expressed sequence tag (est) entries
on the right contains a small scale RFX immunoprecipitation that
that matched the peptides and gene sequence werewas labeled with PKA and 32P-gATP that was run in parallel with the
found in the human est database. Oligonucleotides wereIP sample. M denotes the marker lanes with the molecular masses
synthesized according to the est sequences and usedindicated.
to screen an expression cDNA library (Strathdee et al.,
1992). Three clones containing a single large open read-
ing frame were obtained. Two of the clones differed onlyidentified three ankyrin repeats within RFX-B that could
in the length of their 59 flanking DNA. The longest clonefunction in protein-protein interactions with the other
was further characterized and called pRFX-B. The thirdRFX subunits and/or X2BP, NF-Y, or CIITA.
cDNA, termed pRFX-BD5, contained two in-frame inter-
nal deletions and was also characterized. Each of these
clones was sequenced and the data are presented inResults
Figure 2A. Other cDNA clones were identified and pur-
chased from the I. M. A. G. E. Consortium database, butPurification and Sequencing of RFX
We hypothesized that one of the two RFX-associated none were longer than those obtained from this screen.
The peptides used to identify the gene are underlined infactors would complement BLS group B cell lines (Mor-
eno et al., 1995). Because group B-derived cell lines the cDNA in Figure 2A. The longest cDNA clone obtained
was 1074 bp, including 148 and 143 bp of 59 leader andgrow poorly in culture, we elected to pursue the cloning
of these genes through a biochemical and reverse ge- 39 trailing sequences, respectively. An AATAAA polyade-
nylation signal was found 16 bp from the poly(A) tail.netic approach (Figure 1A). A nuclear extract, prepared
from a 50 liter culture of the MHC class II positive B The longest open reading frame (783 bp) encoded a 261
amino acid protein with a predicted molecular mass oflymphoblastoid cell line Raji, was chromatographed
through heparin agarose and then through a Hi-trap Q 28.1 kDa. The clone termed pRFX-BD5 had two in-frame
deletions that appear to be the result of differential RNAcolumn as we described previously (Hasegawa and
Boss, 1991). To ensure that all components of RFX were splicing. The structure of pRFX-BD5 will be discussed
below. Although the RFX-B protein does make contactretained during purification, Western blotting and immu-
noprecipitations using the RFX5 specific antisera RFX5c with DNA (Westerheide and Boss, unpublished data),
no known DNA-binding domain was detected using a(Moreno et al., 1997) were performed (data not shown).
To visualize the RFX components, immunoprecipitates variety of sequence homology search programs. Fur-
ther, analysis of the protein sequence showed that thewere labeled with protein kinase A (PKA) as described
Cloning of RFX-B
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Figure 2. Sequence of the RFX-B cDNA and
Ankyrin Repeat Homology
(A) The DNA sequence of the RFX-B cDNA is
shown with the corresponding open reading
frame. A PEST homology domain is boxed.
The three ankyrin repeat homology domains
are indicated by dashed underlining of pro-
tein sequence. Thin vertical lines denote the
exon boundaries. DNA corresponding to in-
tron 1 found in the longest RFX-B cDNA is
shown at the beginning of the sequence in
italics. In pRFX-BD5, exon 5 is completely
eliminated as are the three base pairs at the
59 junction of exon 4 (indicated by a vertical
line and an asterisk). Solid lines correspond
to the peptide sequences that were derived
by Edman degradation. The frameshifted
stop codon in the BLS mutant lines is boxed
in Exon 9. The canonical poly(A) signal is also
boxed. Reference indicators for bp, aa, and
exons are shown on the right.
(B) Homology of RFX-B sequence to ankyrin
repeats. Using the Sanger Center Pfam/pro-
tein families database programs, homology
to the ankyrin repeats were found and are
aligned with the consensus sequence. Identi-
cal amino acids are shown and 1 indicates
amino acids of similar nature. Amino acid po-
sitions for RFX-B are indicated.
N-terminal portion of the protein is highly acidic (21% RFX-B Complements BLS-Group B Cell Lines
To determine if the RFX-B cDNA clone could comple-for residues 2±64) and rich in proline, glutamic acid,
serine, and threonine residues. While this region was ment BLS-group B cell lines, two experimental ap-
proaches were undertaken. First, the ability to restoreidentified initially as a PEST domain, a homology domain
that is found in many proteins with short half-lives (Rog- surface expression was examined. Cells representing
each of the complementation groups were transfecteders et al., 1986), the sequence had only a single down-
stream lysine and was not surrounded by basic residues with pRFX-B, pRFX-BD5, and the pREP4 control vector.
At 72 hr, cells were stained with I3-RD1, a pan MHCthat are a hallmark of this type of domain. Alternatively,
acidic domains and proline-rich domains have been class II antibody, and analyzed by flow cytometry (Figure
3A). Only group B cells (Nacera and Bequit) showedfound in transcription factors and have been shown to
function as transcriptional activation domains (Ma and restoration of surface MHC class II expression. Both the
vector control and the pRFX-BD5 did not induce thePtashne, 1987; Sadowski et al., 1988; Mermod et al.,
1989; Mitchell and Tjian, 1989). Three ankyrin homology expression of MHC class II on the surfaces of any of
the cells. Thus, the protein product encoded by pRFX-motifs were identified and are highlighted in Figure 2A.
Ankyrin domains function in protein-protein interactions BD5 is not involved in the positive regulation of MHC
class II genes. An IgG isotype control was performed for(Bork, 1993), are typically 33 amino acids in length, and
are found arrayed tandemly in many proteins. They are all flow cytometry analysis and showed no nonspecific
staining (data not shown).defined by the potential secondary structures that they
can form (Bork, 1993). Figure 2B shows a comparison After selection for the plasmid with hygromycin, pRFX-B
transfected Bequit cells were aliquoted and stained withof the RFX-B ankyrin repeats with ankyrin. The presence
of these ankyrin domains suggests regions of interaction antisera specific for each of the MHC class II isotypes.
The cells were then analyzed by flow cytometry andbetween RFX-B and other proteins involved in MHC
class II regulation. sorted for expression of surface MHC class II (Figure 3B).
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Figure 3. The RFX-B Gene Complements BLS-Group B
(A) Cells representing each of the complementation groups were transiently transfected with 40 mg of pRFX-B, pRFX-BD5, or pREP4 as a
negative control vector. 72 hr post transfection, cells were stained with a pan MHC class II antibody or isotype control and analyzed by flow
cytometry. Shaded histograms indicate cells transfected with either pRFX-B or pRFX-BD5 plasmids. Open histograms indicate cells transfected
with the control pREP4 vector.
(B) RFX-B expression in BLS group B cells restores all class II isotypes. Bequit cells stably transfected with pRFX-B were aliquoted and
stained and sorted for expression of HLA-DR, HLA-DQ, or HLA-DP (Pre sort). Sorted cells were reanalyzed by flow cytometry as shown (Post
sort). Untransfected Raji and Bequit cells were stained and analyzed as indicated. Shaded histograms indicate cells stained with the indicated
antibody. The corresponding conjugated isotype control is indicated by open histograms.
The sorted population was reanalyzed for expression of CAT protein was detected in the control transfection
containing reporter without WXY box (pDRCAT) andthe MHC class II isotype with which they were selected
(Figure 3B). This analysis showed that the expression pRFX-B, which was not observed in the other transfec-
tions. While this activity has been inconsistent, it couldof RFX-B induced the expression of all three MHC class
II isotypes HLA-DR, -DQ-, and -DP. Raji cells, which imply that RFX-B, in addition to regulating MHC class
II genes, may regulate other genes in the cell. Nonethe-are wild-type for class II expression, and untransfected
Bequit cells, were also stained and analyzed with each less, these assays demonstrate that RFX-B can function
through the MHC class II promoter.of the antisera (Figure 3B). Compared to Raji cells, Be-
quit cells transfected with pRFX-B produced slightly
less of the class II products. This may be due to the
heterogeneity of the transfected population of cells or Genomic Structure and Location of the RFX-B Gene
Nucleic acid database searches revealed that the RFX-Bthe overall level of RFX-B expression in the transfected
cells. gene was encoded on chromosome 19 within three
sequenced cosmids (accession numbers: AC003110,Second, to demonstrate that RFX-B is functioning
through the promoter of MHC class II genes, the ability CH19R27740, and AC002126). This analysis placed the
RFX-B gene at 19p12 between genes for MEF2B andof the gene to activate a WXY driven-CAT reporter ver-
sus a control CAT reporter lacking these sequences NEUC, which encode the myocyte specific enhancer
factor 2B and neurocan chondroitin sulfate proteogly-was tested. Transient cotransfections of pRFX-B, pRFX-
BD5, or pREP4 with either the pDRCATwt (WXY con- can genes (Figure 5). By comparing the cDNA to the
genomic sequence, the exon-intron relationship wastaining) or pDRCAT (control) reporters were carried out
in the BLS-group B line Bequit. Essentially no in- determined. The clones presented here are encoded
in nine exons. Recently, a cDNA containing a longerduction was observed when pREP4 was transfected
(Figure 4). A strong induction of expression was ob- 59 untranslated region was reported (Masternak et
al., 1998). The 59 end of this clone, termed RFX-Ank,served when both pRFX-B and the WXY containing re-
porter (pDRCATwt) were used (Figure 4). A low level of mapped to an additional 59 exon, exon 1. None of the
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Figure 6. Genomic Structure of the RFX-B Gene
The exon/intron organization of the RFX-B gene was derived by
comparing the cDNA sequences and the genomic sequence. The
ten exons are denoted. The position of exon 1 was inferred fromFigure 4. RFX-B Restores Expression to an MHC Class II Promoter-
the sequence reported for RFX-Ank (Masternak et al., 1998). OpenDriven Reporter Vector
boxes represent untranslated portions of the transcribed mRNA.
The BLS group B cell line Bequit was transiently transfected with Shaded boxes, small circle, and lines indicate potential alternative
pRFX-B, pRFX-BD5, or pREP4, a SV40-driven luciferase control vec- splicing events. Potential alternative splicing products detected by
tor, and a CAT reporter driven by the WXY conserved sequences nonlinear RT-PCR in Bequit and Nacera are schematically illus-
of MHC class II genes (pDRCATwt) or the matching vector with trated. The 26 bp deletion mutation at the intron 5/exon 6 boundary
these sequences deleted (pDRCAT). CAT assays were normalized is denoted by a circle.
to the luciferase values to control for transfection efficiency. The
average of three experiments is shown with the standard error of
the mean indicated. exons spanning z9.6 kb of DNA (Figure 6). The protein
coding portion of this gene begins in exon 3.
Sequence comparisons between the pRFX-BD5 and
the genomic sequence revealed an interesting doubleclones obtained here or in the IMAGE consortium data-
splice variant. The first variation was at the intron 3/exonbase contained sequences in exon 1. Oddly, the longest
4 junction where the second and third bp of exon 4,clone identified herein begins in intron 1, containing
an AG dinucleotide, were used as the splice acceptor,the last 13 bp of that intron. This is most likely due
eliminating the first codon of exon 4. The second alterna-to alternative processing. Preliminary primer extension
tive splice leaves out exon 5; hence the name RFX-BD5.analysis identified transcripts beginning close to the
Together, these alternative splice variants result in thestart of the longest cDNA clone reported here (intron1/
elimination of an alanine codon at the beginning of exonexon2), as well as transcripts initiating upstream of the
4 and the creation of a cysteine codon at the new junc-59 boundary of exon 1 (data not shown). Together, these
tion between exons 4 and 6. As described below, RT-data suggest that RFX-B is most likely encoded in ten
PCR products can be found in Raji cells that represent
the RFX-D5 splice variation.
Bequit and Nacera BLS Cell Lines Contain a Small
Deletion in the RFX-B Gene
Four approaches were employed to determine the ge-
netic basis for two of the BLS-group B patients: expres-
sion analysis, cDNA cloning, Southern blotting, and ge-
nomic DNA sequencing. Using a cDNA probe spanning
exons 4±10 of RFX-B, Northern blot analysis was per-
formed on RNA isolated from the cell lines Raji, Bequit,
Nacera, and representatives of the other complementa-
tion groups (Figure 7A). An mRNA of the expected size
of z1 kb was observed in Raji, RJ2.2.5 (group A), SJO
(group C), and 6.1.6 (group D) cells. No hybridization
signal was observed in RNAs from both Bequit and Nac-
era cells. Equal loading and preparation of RNA samples
was demonstrated by reprobing the blot for glyceralde-
hyde dehydrogenase RNA (Figure 7A). The lack of RFX-B
mRNA in Bequit and Nacera suggests that the RFX-B
gene may be deleted, contain a deletion in the region
probed, may be silenced, or that the transcript is ex-
tremely unstable.
To distinguish between these possibilities, the sensi-
tivity of RT-PCR analysis was employed to determine ifFigure 5. The RFX-B Gene Is on Chromosome 19p12
low levels of the transcript could be detected. Primers
The schematic diagram was redrawn according to the data on the
were designed that would amplify various portions ofHuman Genome Center's web page (http//www.bio.llnl.gov/genome/
the RFX-B gene. A primer set that would amplify DNAhtml). The position of the RFX-B gene was determined by its position
to the genes linked to it in the sequenced database. spanning exons 4±9 produced a major RT-PCR product
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Figure 7. The Mutation in BLS Group B Cell
Lines Nacera and Bequit Is a 26 bp Deletion
Encompassing a Splice Acceptor that Results
in Unstable mRNA
(A) Northern blot analysis of RNA prepared
from the indicated cell lines for the expression
of RFX-B and glyceraldehyde dehydroge-
nase (GAPDH) is shown. RFX-B transcripts
were not detected in BLS-group B cell lines
Nacera and Bequit. Complementation groups
are listed. W denotes wild-type Raji cell lanes.
(B) RT-PCR analysis of all complementation
groups. Lanes in which reverse transcriptase
(RT) was added are indicated. The arrow de-
notes the major product from Bequit and
Nacera that was sequenced directly.
(C) Comparison of the genomic DNA se-
quence in intron 5 and exon 6 from Raji, Be-
quit, and Nacera. Lowercase and uppercase
letters indicate intron and exon sequences,
respectively.
(D) Only one allele is present in Bequit and
Nacera. Genomic Southern blot of EcoRI
cleaved DNA from the indicated cells is shown
probed with a cDNA encoding exons 4±10.
(E) Exons 4±8 were amplified from genomic
DNA of the indicated cell lines and a Southern
blot was performed using an oligonucleotide
probe for 26 bp deleted region in intron 5 or
similar size oligonucleotide encoding exon 4.
(Figure 7B, upper band) and a minor product (lower) in and analyzed by hybridization and/or restriction analy-
sis. Of the 60 clones analyzed, 2% contained exon 5wild-type Raji cells. The DNA in these bands was ex-
cised, cloned, and sequenced. The sequence of the and none had exon 6. Thus, both Bequit and Nacera
have a mutation that effects RNA processing.major PCR product was identical to the full-length cDNA,
while the minor product represented the alternative Because deletion of exon 5 could arise through the
alternative splicing mechanism present in pRFX-BD5 insplice variant in which exon 5 was deleted as in pRFX-
BD5. Thus, both splice products are present in wild-type which exon 5 is not included in the mRNA, the mutation
might lie in the splice acceptor sequence for exon 6. Tocells. A similar analysis in Bequit and Nacera resulted in
a major and several minor PCR species (Figure 7B). locate the mutation, DNA spanning exons 4 through
8 were amplified from Raji, Bequit, and Nacera cells,However, even after 35 cycles, the intensity of these
bands was substantially less than those produced from subjected to automated DNA sequence analysis, and
compared. The results showed that both cell lines con-the other cells analyzed. The major product (arrow) from
Bequit and Nacera RT-PCR reactions was excised and tain the same 26 bp deletion (Figure 7C). This mutation
spans the 39 side of intron 5 and extends one bp intosequenced. In both Bequit and Nacera, this RT-PCR
product encoded a fusion between exon 4 and 7, most exon 6. Thus, the splice acceptor site of exon 6 is miss-
ing, and the transcript is spliced to exon 7 directly. Be-likely due to an RNA splicing event. A similar RT-PCR
reaction was performed and the products were cloned cause of the codon structure at the end of exon 4 and
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5, this splice results in a frame shift and the production Is the RFX Complex Now Defined?
Several lines of evidence suggested that the RFX com-of a UGA stop codon in the beginning of exon 9 (Figure
2A). Following the frameshift mutation, 33 amino acids plex consisted of three distinct subunits. Data generated
from genetic complementation studies (Benichou andare encoded prior to the new nonsense codon. We sug-
gest that this aberrant transcript is less stable than the Strominger, 1991; Seidl et al., 1992), in vivo footprinting
(Kara and Glimcher, 1991; Westerheide et al., 1997), andfull-length transcript, resulting in the lack of detection
by Northern blot hybridization. DNA-binding analyses (Reith et al., 1988; Stimac et al.,
1991; Herrero-Sanchez et al., 1992; Hasegawa et al., 1993)Because only one mutation was uncovered, a South-
ern blot was carried out to determine hetero/homozy- showed that three BLS complementation groups (B, C,
and D) lacked RFX activity and had unoccupied promot-gosity of the RFX-B gene in the mutant cells. DNA from
Raji, Bequit, and Nacera cells was digested with EcoRI ers in vivo. The simplest interpretation of these findings
was that the RFX factor consisted of at least three dis-and probed with an exon 4±10 cDNA probe. Only a single
band of approximately 14 kb (13.4 kb predicated from tinct subunits, with each subunit representing a sepa-
rate complementation group. Metabolic labeling andgenomic sequence) was detected in all three cell lines
(Figure 7D). The EcoRI fragment spans the entire gene coimmunoprecipitations of RFX using RFX5 specific an-
tisera identified two associated proteins, thereby lim-and is of the expected size. Digestions with HindIII or
XhoI, which cut inside the gene, did not reveal any differ- iting the number of distinct subunits to three (Moreno
et al., 1997). Prior to the current protein sequence analy-ences between the cell lines (data not shown). To be
sure that the DNA representing the 26 bp deletion was ses, it was predicted that the 33 kDa migrating protein
was RFXAP based on its predicted molecular weight ofnot in the genome of the mutant cell lines, PCR amplifi-
cation of the genomic DNA spanning exons 4±8 was 36 kDa. The current data eliminates this conclusion and
clearly shows that the 41 kDa migrating protein isperformed and analyzed by Southern hybridization to
an oligonucleotide encoding the 26 bp deleted region. RFXAP. These results, however, do not address the
numbers of each subunit. We have recently completedA positive signal was detected in Raji cells but no signal
was detected in Bequit and Nacera cells (Figure 7E). To a photocross-linking study showing basepair specific
contacts of all three RFX subunits (Westerheide andensure that both cell lines represented different individu-
als, the cells were subjected to DNA fingerprint analysis Boss, unpublished data). This study showed discrete
and limited contacts of RFX5 and RFX-B at the 59 and(courtesy of Dr. A. Eisenberg, University of North Texas
Health Science Center). This analysis confirmed that the 39 halves of the X1 box, respectively, predicting that
only one molecule of each of these subunits is part ofcell lines were derived from different individuals (data
not shown). Together, these data support the conclusion the RFX complex. RFXAP, however, was found to make
extensive contacts along the X1 box. These resultsthat the RFX-B allele in these patients is homozygous.
This conclusion is further supported by the fact that were interpreted to suggest that RFXAP may interact
electrostatically along the phosphate backbone or thatboth cell lines were derived from patients from the same
geographical location and were the result of consan- the stoichiometry of the RFXAP in the complex is greater
than one.guinity (Lisowska-Grospierre et al., 1994).
Discussion
Role of Ankyrin Repeats
A BLAST database search of the RFX-B ankyrin repeatThe gene responsible for the defect in BLS-group B cell
sequence produced more than 100 significant matcheslines represented the last of the defined MHC class II
that span the animal kingdom. These domains are typi-transcription factors and X box proteins. Here, we have
cally 33 amino acids in length and are found in multipleidentified this gene and demonstrated that it can com-
copies in proteins (Bork, 1993). Ankyrin repeats functionplement the mutations in BLS group B patient derived
in protein-protein interactions. For example, the ankyrincell lines. Additionally, we have been able to identify the
repeats of the Swi6 yeast G1/S specific transcriptionbasis of this disease in two patients.
factor are involved in factor-factor association with Swi4Two splice forms of the RFX-B gene were discovered.
(Ewaskow et al., 1998). Another example is the domainThis was unexpected, as the immunoprecipitations of
located in IkB. These ankyrin repeats function to associ-the RFX complex yielded a single band migrating with
ate IkB with NF-kB (Baldwin, 1996). With which subunitsa relative molecular mass of 33 kDa in SDS-PAGE. This
or factors do the RFX-B ankyrin repeats interact? Asso-would initially suggest that only one of the splice variants
ciations between RFX5 and RFXAP or RFX5 and RFX-Bis involved in MHC class II expression. Protein sequenc-
were not detected in cells lacking RFX-B or RFXAP,ing of the peptides produced a fortuitous result in that
respectively (Moreno et al., 1997). These coimmuno-one of the peptides sequenced spanned the junction
precipitations were carried out in the absence of DNA;between exon 4 and 5: the spliced region (Figure 2).
thus, it is most likely that the complex forms prior toThus, the protein associated with RFX contains exon 5.
DNA binding and that all three proteins must be presentEvidence that the splice form actually exists is currently
for interactions to occur. Perhaps the ankyrin repeatslimited to the cDNA cloning and the RT-PCR analysis.
of RFX-B allow the three subunits to associate with eachThus, the current data indicate that RFX-BD5 is not in-
other. Because RFX forms cooperative DNA bindingvolved in the positive regulation of MHC class II genes.
complexes with X2BP and NF-Y (Reith et al., 1994a;However, these data do not rule out the intriguing possi-
Moreno et al., 1995; Louis-Plence et al., 1997), it is possi-bility that this form could negatively regulate MHC class
ble that interactions between these factors could comeII expression if the factor can interact with the other
subunits. from each of the ankyrin repeats. Alternatively, since
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agarose using a gradient of 0.100 to 1 M KCl. RFX was monitoredthere are three repeats, one or more could function in
by Western blotting for RFX5 and coimmunoprecipitation of theRFX assembly and the other(s) in factor-factor interac-
three subunits using the RFX5c antisera (Moreno et al., 1997). RFXtions. Still, an additional possibility is that these repeats
containing fractions were pooled and fractionated over a 5 ml Hi-
are involved in interactions with CIITA. We showed pre- Trap Q column (Pharmacia Inc., Piscataway, NJ) using a gradient
viously that CIITA required an intact X1 box for its activity of 0.06 to 0.6 M KCl. Fractions with the highest concentration of
RFX were pooled. The RFX complex was further purified from this(Riley et al., 1995). Using a yeast two-hybrid assay,
pool by immunoprecipitation using antisera to the RFX5 subunitScholl et al. (1997) observed weak interactions between
that was covalently attached to magnetic beads (see below). EightRFX5 and CIITA. However, supporting data for those
ml of anti-RFX5c beads were mixed with the high activity pool forinteractions or interactions between CIITA and RFXAP,
3 hr. The beads were collected and washed four times in 10 ml of
X2BP, or NF-Y have not been reported to date. 50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 50 mM NaF, and 1% NP-
40. The RFX complex was eluted from the beads using 0.53 -PAGE
buffer (5% SDS, 5% glycerol, 0.03 M Tris [pH 6.8], and 0.005%BLS Group B
bromophenol blue) and concentrated to 23 under vacuum. TheOf the naturally occurring class II negative cell lines
sample was further purified by SDS-PAGE using a 9% gel. Thedescribed, BLS group B represents the predominant
bands corresponding to RFX were excised and submitted to bothgroup. Over 14 patients have been described from this
the Yale University and Emory University Microchemical Facilities
group (Lisowska-Grospierre et al., 1994). Many of the for sequencing. In both facilities, in-gel tryptic digestions were car-
patients have their origins in Northern Africa and are ried out and the peptides were purified by microbore HPLC. MALDI-
TOF mass spectrometry was used to determine the molecular mass/the result of consanguineous relationships (Lisowska-
charge ratios of the peptides and search the databases. EdmanGrospierre et al., 1994). Bequit and Nacera, the two cell
degradation was also carried out on selected peptides as describedlines examined here, have inherited the same mutation.
in the text.Our data suggests that the mutant allele is homozygous
for four reasons. First, only one allele is detected by RT- Antibody Affinity Resin
PCR of RNA or PCR of genomic DNA. Second, Southern Approximately 60 ml of crude RFX5c antisera (Moreno et al., 1997)
blotting of DNA spanning the gene did not reveal any was cleared by passage over an Escherichia coli lysate attached to
sepharose. The IgG portion of the sera was isolated from the flowpolymorphism or additional alleles. Third, genomic se-
through by chromatographic separation over a Hi-Trap A columnquencing of PCR amplified DNA showed only one se-
(Pharmacia, Inc., Piscataway, NJ). To enrich for the RFX5 reactivequence. Fourth, because both of these patients are from
antibodies, a peptide affinity column was constructed. The peptides
the same geographical area, it is possible that they have that were used to generate this antisera (Moreno et al., 1997) were
inherited the same allele. However, these data do not covalently attached to a 1 ml NHS-activated Hi-Trap column (Phar-
rule out the possibility of a larger deletion within this macia, Inc., Piscataway, NJ) following the manufacturer's protocols.
The IgG fractions were then bound to the peptide affinity columnregion, which would have resulted in a hemizygous
in phosphate-buffered saline, eluted in 100 mM glycine (pH 3.0),state. Substantial linkage analysis to close and distant
and neutralized with 1 M Tris-Cl (pH 8.8). The RFX5 specific antibod-markers will be required to determine this outcome.
ies were dialyzed against phosphate-buffered saline. The anti-
The identity of RFX-B completes the complex and body:bead ratio was maximized for optimal binding by titration. Six
opens the door to novel avenues of regulation of MHC mg of RFX5 antibodies were covalently linked to 8 ml of tosyl-
class II genes. The RFX subunits appear to be expressed activated magnetic beads (Dynal Inc., Lake Success, NY) according
to the manufacturer's protocol. Following the linkage of the antibodyubiquitously. However, the degree to which the proteins
to the beads, dimethyl pimelidate was added to a concentration ofare expressed varies between cell types. Coimmuno-
2.5 mM to cross-link the heavy and light chains of IgG and preventprecipitations found that all three of the RFX compo-
their dissociation and interference during the purification of RFX.
nents were about 20-fold less abundant in fibroblasts
than in B cells (Moreno et al., 1997). Moreover, treatment cDNA Cloning and Sequence Analysis
of cells with interferon-g did not change the level of A B cell cDNA library (Strathdee et al., 1992) constructed in pREP4
these proteins. This may suggest that there is some (Invitrogen Inc., Carlsbad, CA) was generously provided by Dr. M.
Buchwald (the Hospital for Sick Children, Toronto). 350,000 coloniescontrol to the expression of these genes. Additionally,
were screened using three oligonucleotides derived from the se-each of these proteins was found to be phosphorylated
quence found in the database 59-GCAGCTCCCTGAAGCACTCCACin vivo, suggesting the potential for posttranslational
CACTC, 5-TCACTCAGGGTCAGCGGGGGCACCAGG, and 59-GTG
control. Targeting interactions within RFX-B could po- AGGTCAGCGCCTCGGGCC. Three positive clones were isolated
tentially disrupt either RFX assembly, DNA binding, or that were full length. All clones were sequenced completely by the
interactions with the other DNA bound factors that may Emory University DNA Sequencing Facility. The accession numbers
for the complete RFX-B sequence and the splice variant RFX-BD5be of use for immune-based therapies in autoimmunity
are AF105427 and AF105428, respectively.and transplantation. The recent finding that CIITA is in-
volved in MHC class I regulation and that RFX-X2BP
Cell Lines and Transfectionscomplexes may be involved (Gobin et al., 1997, 1998;
The complementation groups for all B cell lines, RJ2.2.5, Bequit,
Martin et al., 1997) suggests an even broader role of Nacera, SJO, and 6.1.6 were described previously (Benichou and
this key transcription factor. Strominger, 1991; Seidl et al., 1992). Raji (Epstein et al., 1966) and
RJ2.2.5 were cultured in RPMI supplemented with 5% fetal bovine
serum, 5% bovine serum, 2 mM glutamine, penicillin (100 units/ml),Experimental Methods
and streptomycin (100 mg/ml). All other cells were cultured in F12-
DMEM media with 20% fetal bovine serum and the above supple-Protein Isolation and Sequencing
Fifty liters of Raji B cells were purchased from Paragon Biotech, ments. Transfections were all performed by electroporation as de-
scribed previously (Riley and Boss, 1993). Stable transformationsInc. A single nuclear extract was prepared from the cell pellet follow-
ing the procedures we have previously described (Moreno et al., were selected 24 hr after electroporation by the addition of hygro-
mycin (100 mg/ml). Samples were analyzed after 10 days of antibiotic1995) with the addition of 0.1% NP-40 to the hypotonic dounce
homogenization solution. The extract was fractionated over heparin selection. Transient transfections contained 20 mg of the pDRCAT
Cloning of RFX-B
161
or pDRCATwt reporter (Riley and Boss, 1993), 10 mg of the indicated Baldwin, A.S. (1996). The NF-kB and IkB proteins: new discoveries
and insights. Annu. Rev. Immunol. 14, 649±681.expression plasmid, and 1 mg of pGL3 (Promega Inc., Madison, WI),
which encodes the firefly luciferase gene. Cells were harvested 72 Benichou, B., and Strominger, J.L. (1991). Class II-antigen-negative
hr post transfection. Ten percent of the cell lysate was analyzed for patient and mutant B-cell lines represent at least three, and probably
expression of the control luciferase product using the Luciferase four, distinct genetic defects defined by complementation analysis.
Assay System (Promega Inc.). The remaining sample was analyzed Proc. Natl. Acad. Sci. USA 88, 4285±4288.
for CAT protein using an ELISA assay (Boerhinger Mannheim Inc., Bork, P. (1993). Hundreds of ankyrin-like repeates in functionally
Indianapolis, IN) according to the manufacturer's directions. The diverse proteins: mobile modules that cross phyla horizontally? Pro-
data were normalized to the expression of the luciferase reporter teins: Struture, Function, and Genetics 17, 363±374.
assay. The average of three experiments is presented.
Boss, J.M. (1997). Regulation of transcription of MHC class II genes.
Curr. Opin. Immunol. 9, 107±113.
Flow Cytometry
Chang, C.-H., Fontes, J.D., Peterlin, B.M., and Flavell, R.A. (1994).Transiently transfected cells were stained with PE-conjugated I3-
Class II transactivator (CIITA) is sufficient for the inducible expres-RD1 or the PE-conjugated isotype control mIg2a (Beckman, Fuller-
sion of major histocompatibility complex class II genes. J. Exp. Med.ton, CA). Surface fluorescence was assayed using a FACScan flow
180, 1367±1374.cytometer (Becton-Dickenson Inc., Franklin Lakes, NJ). Stable trans-
Chin, K.-C., Mao, C., Skinner, C., Riley, J.L., Wright, K.L., Moreno,fected cells were stained with either PE-conjugated HLA-DR, FITC-
C.S., Stark, G.R., Boss, J.M., and Ting, J.P.-Y. (1994). Molecularconjugated HLA-DQ, HLA-DP (Becton-Dickenson Inc., Franklin
analysis of G1B and G3A IFN-g mutants reveals that defects inLakes, NJ), or the corresponding conjugated Ig isotype control anti-
CIITA or RFX result in defective class II MHC and Ii gene induction.sera described above. Secondary staining with FITC-conjugated
Immunity 1, 687±697.sheep anti-mouse IgG (Becton-Dickenson Inc., Franklin Lakes, NJ)
was required for detection of HLA-DP. The samples were sorted for de Preval, C., Lisowska-Grospierre, B., Loche, M., Griscelli, C., and
expression of the isotype with which they were stained using a Mach, B. (1985). A trans-acting class II regulatory gene unlinked to
FACSvantage cell sorter (Becton-Dickenson Inc., Franklin Lakes, the MHC controls expression of HLA class II genes. Nature 318,
NJ). A portion of each sorted sample was reanalyzed for expression 291±293.
of HLA-DR, -DQ, or DP as indicated. Durand, B., Sperisen, P., Emery, P., Barras, E., Zufferey, M., Mach,
B., and Reith, W. (1997). RFXAP, a novel subunit of the RFX DNA
RNA and DNA Hybridization Analyses binding complex, is mutated in MHC class II deficiency. EMBO J.
RNA was extracted from cultured cells using the NP-40 lysis method 16, 1045±1055.
(Sambrook et al., 1989; Gordon et al., 1992) or using the RNAeasy Elhasid, R., and Etzioni, A. (1996). Major histocompatibility complex
kit (Qiagen Inc., Santa Clarita, CA). Northern blot analysis was car- class II deficiency: a clinical review. Blood. Rev. 10, 242±248.
ried out as described previously (Ping et al., 1996) using random
Epstein, M.A., Achong, B.G., Barr, Y.M., Zajac, B., Henle, G., andprimed RT-PCR amplified RNA spanning exons 4±8 (see below).
Henle, W. (1966). Morphological and virological investigations onGenomic DNA was isolated using standard procedures (Ausubel et
cultured Burkitt tumor lymphoblasts (strain Raji). J. Natl. Cancer.
al., 1987). Seven mg of DNA was digested overnight with EcoRI and
Inst. 37, 547±559.
analyzed using standard Southern blotting methods. Hybridization
Ewaskow, S.P., Sidorova, J.M., Hendle, J., Emery, J.C., Lycan, D.E.,was carried out using the exon 4±10 RT-PCR product described
Zhang, K.Y., and Breeden, L.L. (1998). Mutation and modeling analy-below.
sis of Saccharomyces cerevisiae Swi6 ankyrin repeats. Biochemistry
37, 4437±4450.RT-PCR and PCR Analyses
Glimcher, L.H., and Kara, C.J. (1992). Sequences and factors: aRT-PCR reactions were carried out using the Perkin Elmer, Inc.
guide to MHC class II transcription. In Annual Reviews of Immunol-(Branchburg, NJ) RT-PCR kit on 0.5 mg of total RNA isolated from the
ogy, W.E. Paul, C. Garrison Fathman, and H. Metzger, eds. (Paloindicated cell types. The exon 4±9 primer set used the following
Alto: Annual Reviews Inc.), pp. 13±50.PCR primers: 59-GCAGCTCCCTGAAGCACTCCACCACTC and 5-TC
ACTCAGGGTCAGCGGGGGCACCAGG. Thirty-five cycles of 45 s at Gobin, S.J.P., Peijnenburg, A., Keijsers, V., and van den Elsen, P.J.
958C, 1 min at 608C, and 75 s (7 min in the last cycle) at 728C were (1997). Site a is crucial for two routes of IFNg-induced MHC class
used to amplify the cDNA for all RT-PCR samples. GAPDH control I transactivation: The ISRE-mediate route and a novel pathway in-
volving CIITA. Immunity 6, 601±611.primers were 59-CCATGGGGAAGGTGAGGTAGGATC and 59-GAG
GAGTGGGTGTCGCTGTTGATC. PCR of genomic fragments for DNA Gobin, S.J.P., Peijneburg, A., van Eggermond, M., van Zutphen, M.,
sequencing of the RFX-B gene consisted of 30 cycles of 30 sec at van den Berg, R., and van den Elsen, P. (1998). The RFX complex
928C, 1 min at 608C, and 3 min at 688C. The last cycle was extended is crucial for the constitutive and CIITA-mediated transactivation of
for 7 min. The DNA was separated on an agarose gel and purified MHC class I and beta 2-microglobulin genes. Immunity 9, 531±541.
for direct DNA sequencing. Gordon, H.M., Kucera, G., Salvo, R., and Boss, J.M. (1992). Tumor
necrosis factor induces genes involved in inflammation, cellular and
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